Key result
Interaction between SSRIs and MAOIs can result in a potentially fatal toxic hyperserotonergic state known as serotonin syndrome.
Why the study?
What are the clinical features and potential lethality of serotonin syndrome resulting from SSRI/MAOI interactions?
What are the clinical features and potential lethality of serotonin syndrome resulting from SSRI/MAOI interactions?
Highlights the critical danger and potential lethality of combining SSRIs and MAOIs due to the risk of serotonin syndrome.
Urges avoidance of SSRI-MAOI co-prescription; leaves open population-level incidence and management data.
The author discusses a relatively new syndrome in which toxic hyperserotonergic states can result from the interaction of different classes of antidepressant drugs. He also distinguishes between this "serotonin syndrome" and neuroleptic malignant syndrome. Using case examples, he demonstrates the potential lethality of SS.
No takes yet. Share an insight, caveat, or question.
Norm Keltner (2009) studied this question. Interaction between SSRIs and MAOIs can result in a potentially fatal toxic hyperserotonergic state known as serotonin syndrome.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: